- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01810861
Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey
SEROTYPE DISTRIBUTION AND ANTIBIOTIC SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE CAUSING INVASIVE DISEASES IN CHILDREN AND ADULTS: A LABORATORY- BASED MULTICENTER RETROSPECTIVE STUDY
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Adana, Turkey, 01330
- Cukurova Universitesi Tip Fakultesi Tibbi Mikrobiyoloji Anabilim Dali
-
Ankara, Turkey, 06100
- Hacettepe Universitesi Tip Fakultesi Cocuk Enfeksiyon Hastaliklari Bilim Dali
-
Ankara, Turkey
- Ankara Meslek Hastalıkları Hastanesi
-
Ankara, Turkey
- Sami Ulus Kadin Dogum Cocuk Sagligi ve Hastaliklari Egitim Arastirma Hastanesi
-
Ankara / Altındağ, Turkey, 06230
- Ankara Yüksek İhtisas Eğitim ve Araştırma Hastanesi Kardiyoloji Kliniği
-
Antalya, Turkey, 07100
- Antalya Egitim ve Arastirma Hastanesi Tibbi Mikrobiyoloji
-
Antalya, Turkey
- Akdeniz University Medical Faculty Microbiology Department
-
Antalya, Turkey
- Akdeniz University Medical Faculty, Microbiology
-
Atakum Samsun, Turkey, 55139
- Samsun Ondokuz Mayis Universitesi Tibbi Mikrobiyoloji ABD
-
Bursa, Turkey
- Uludag Universitesi Tip Fakultesi Mikrobiyoloji ve Enfeksiyon Hastaliklari Anabilim Dali
-
Diyarbakir, Turkey, 21280
- Diyarbakir Dicle Universitesi Tibbi Mikrobiyoloji ABD
-
Diyarbakir, Turkey
- Dicle Universitesi Tip Fakultesi Tibbi Mikrobiyoloji Anabilim Dali
-
Elazig, Turkey
- Firat Universitesi Tip Fakultesi Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali
-
Eskisehir, Turkey
- Osmangazi University Medical Faculty, Microbiology
-
Istanbul, Turkey, 34662
- Marmara Universitesi Tip Fakultesi
-
Istanbul, Turkey
- Istanbul Universitesi Cerrahpasa Tip Fakultesi Cocuk Sagligi ve Hastaliklari Ana Bilim Dali
-
Izmir, Turkey
- Ege University Medical Faculty, Microbiology
-
Kagithane Istanbul, Turkey, 34000
- Istanbul Okmeydani Egitim ve Arastirma Hastanesi Kagithane Semt Poliklinii
-
Kahramanmaras, Turkey
- Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Tibbi Mikrobiyoloji Anabilim Dali
-
Kayseri, Turkey
- Erciyes University Medical Faculty
-
Kayseri, Turkey
- Kayseri Training and Research Hospital
-
Konak Izmir, Turkey, 35210
- Izmir Dr. Behcet Uz Cocuk Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi
-
Konya, Turkey
- Necmettin Erbakan University Meram Faculty of Medicine Deparment of Pediatrics
-
Mersin, Turkey
- Mersin University Medical Faculty, Microbiology
-
Samanpazari, Ankara, Turkey, 06100
- Hacettepe University Medical Faculty Hospital
-
Selcuklu /konya, Turkey, 42075
- Selcuk Universitesi Tip Fakultesi Dahili Tip Bilimleri Bolumu Cocuk Sagligi ve Hastaliklari A.B.D
-
Trabzon, Turkey
- Karadeniz Teknik Universitesi Tip Fakultesi Tibbi Mikrobiyoloji Anabilim Dali
-
Van, Turkey
- Van 100.Yl University Medical Faculty
-
İzmir, Turkey
- İzmir Tepecik Rearch and Training Hospital
-
-
Izmir
-
Balcova, Izmir, Turkey, 35340
- Dokuz Eylul University Medical Faculty, Department of Chest Diseases
-
-
Turkiye
-
Gaziantep, Turkiye, Turkey
- Gaziantep Universitesi Tip Fakultesi Mikrobiyoloji
-
Istanbul, Turkiye, Turkey
- Istanbul Universitesi Istanbul Tip Fakultesi Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Pneumococcal isolates that are obtained from the blood, CSF and/or other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL) with the aim of routine laboratory diagnosis from the pediatric patients that are younger than 18 years old (≤18), who are accepted to the pediatric clinic with the diagnosis of meningitides, bacteremia - sepsis or pneumonia, will be included in the trial.
S.pneumoniae isolates that meet the inclusion criteria and that are obtained from the invasive clinical samples of the adult patients that are over 18 years old (>18) and applied to the hospital are included in the trial.
Description
Inclusion Criteria:
Serotype distribution and antibiotic sensitivity of pneumococcal isolates that causes invasive pneumococcal diseases which are obtained from the blood, CSF, and/or all other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL) of the adults of 18 years of age or older with children that are younger than 18 years old at these centers and laboratories will be defined.
Exclusion Criteria:
Isolation of any other microorganism than pneumococcus at the same sample.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Serotype distribution (this is a non-interventional study)
Serotype distribution both in pediatrics and adults (this is a non interventional study)
|
This is a non-interventional study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Identification of S. pneumoniae serotype distribution
Time Frame: 4 years
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Identification of antibiotic susceptibility of the isolates
Time Frame: 4 years
|
4 years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B1851148
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumococcal Diseases
-
University of OttawaNot yet recruitingPneumococcal Vaccine Uptake | Vaccination Willingness | Pneumococcal Vaccine Knowledge | Pneumococcal Vaccine AttitudeCanada
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedVaccines, Pneumococcal | Vaccines, Pneumococcal Conjugate Vaccine
-
PfizerCompletedPneumococcal Vaccines | Pneumococcal Conjugate VaccineJapan
-
Johns Hopkins Bloomberg School of Public HealthPfizer; National Institutes of Health (NIH); Centers for Disease Control and...CompletedInvasive Pneumococcal Disease | Pneumococcal Nasopharyngeal ColonizationUnited States
-
Institut National de la Santé Et de la Recherche...CompletedPneumococcal DiseasesFrance
-
GlaxoSmithKlineCompletedProphylactic Pneumococcal DiseasesBelgium
-
Vaxcyte, Inc.CompletedPneumococcal VaccinesUnited States
-
EpicentreKenya Medical Research Institute; LSHTM; Universite Abdou Moumouni de Niamey UAMActive, not recruitingPneumococcal CarriageNiger
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedVaccines, PneumococcalGermany
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedPneumococcal VaccinesUnited States
Clinical Trials on There is no intervention in this study
-
ProgenaBiomeRecruitingGastrointestinal Microbiome | Gut MicrobiomeUnited States
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of British Columbia; Alberta Health... and other collaboratorsCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOcular Hypertension | Glaucoma, Open-AngleCanada
-
University of GeorgiaCompletedHuman PapillomavirusUnited States
-
ProgenaBiomeRecruitingCoronaviridae Infections | COVID-19 | COVID 19 | COVID | Corona Virus Infection | Coronavirus | Gastrointestinal Microbiome | Gut Microbiome | Coronavirus-19 | Coronavirus 19United States
-
University of HaifaRambam Health Care CampusCompletedParkinson DiseaseIsrael
-
New York Medical CollegeRecruitingIntestinal Obstruction | Trauma Abdomen | Intestinal PerforationUnited States
-
Tianjin Happy Life Technology Co., Ltd.Unknown
-
Huazhong University of Science and TechnologyNational Natural Science Foundation of ChinaRecruitingAllergic Rhinitis | SARS-CoV-2 | Allergen ImmunotherapyChina
-
University of VirginiaCompletedCancer | Motivation | Smoking BehaviorsUnited States